Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent Highlight

ACS Med Chem Lett. 2012 Nov 27;4(1):18-9. doi: 10.1021/ml300405d. eCollection 2013 Jan 10.
No abstract available